1e
19
1
49
2
2
18
1b
1d
18
35
4e
1d
2 29
1d
25
Christopher Perrone, MD
88
4e
Associate Professor of Clinical Neurology
28
70
3
60
Associate Clerkship Director, Perelman School of Medicine
7d
Neurology Outpatient Epic Governance Chair, University of Pennsylvania
11
Department: Neurology
4
1
b
1d
46
Contact information
70
4
3
3
3
2
4
b
1f
70
3400 Spruce Street, 3 W. Gates Building
Philadelphia, PA 19104
26
Philadelphia, PA 19104
2e
Office: 215-662-3606
30
b5
12
30
13
Education:
21 9 B.S. 23 (Biology and Psychology) c
36 Tufts University, Medford, MA, 2010.
21 9 M.D. c
52 University of Massachusetts Medical School, Worcester, MA, 2014.
c
3
3
3
3
8d
Permanent link21 9 B.S. 23 (Biology and Psychology) c
36 Tufts University, Medford, MA, 2010.
21 9 M.D. c
52 University of Massachusetts Medical School, Worcester, MA, 2014.
c
2 29
21
1e
1d
24
2b
29
27
23
1a3 Cooper EC, Schindler MK, Bar-Or A, Brandstadter RB, Calkins ME, Gur R, Jacobs DA, Markowitz C, Moore T, Naydovich LR, Perrone CM, Ruparel K, Spangler BC, Troyan S, Shinohara RT, Satterthwaite TD, Baller EB: Investigating mood and cognition in people with multiple sclerosis: A prospective cross-sectional study protocol. BMJ Open 15(5), May 2025.
148 Baller EB, Luo AC, Schindler MK, Cooper EC, Pecsok MK, Cieslak MC, Martin ML, Bar-Or A, Elahi A, Perrone CM, Spangler BC, Satterthwaite TD, Shinohara RT: Uncinate Fasciculus Lesion Burden and Anxiety in Multiple Sclerosis. JAMA Netw Open 8(4), April 2025.
1b1 Martin ML, Robert-Fitzgerald T, Schindler MK, Perrone C, Schultz G, Lynch S, Mirkovic N, Thomas S, Elahi A, Reid D, Moore TM, Baller EB, Satterthwaite TD, Cieslak M, Covitz S, Adebimpe A, Manning A, Markowitz CE, Detre JA, Bar-Or A, Kakara M, Shinohara RT.: Impact of insurance status on MRI phenotypes in MS. Mult Scler Relat Disord 92(105919), December 2024.
1cd Oh J, Smolders J, Buijs F, Meyer zu Hörste G, Perrone C, van den Brand J, Federer-Gsponer J, Pedotti R, Kaczmarek L, Sharma V, Heinzmann D, Tackenberg B, Bar-Or A, Wiendl H: Defining PIRA and Lack of Disease Stability in the Real-World: Interim Results. European Committee for Treatment and Research in Multiple Sclerosis November 2024 Notes: Poster presentation; presented by co-author.
1de Baller EB, Sweeney EM, Cieslak MC, Robert-Fitzgerald T, Covitz SC, Martin ML, Schindler MK, Bar-Or A, Elahi A, Larsen BS, Manning AR, Markowitz CE, Perrone CM, Rautman V, Seitz MM, Detre JA, Fox MD, Shinohara RT, Satterthwaite TD: Mapping the relationship of white matter lesions to depression in multiple sclerosis. Biol Psychiatry 95(12): 1072-1080, June 2024 Notes: doi: 10.1016/j.biopsych.2023.11.010.
1a9 Son JY, Hu C, McAlpine L, Bar-Or A, Dahl M, Brito SF, Kavak K, Onomichi K, Perrone C, Riley C, Song E, Walker E, Weinstock-Guttmen B, De Jager P, Longbrake E, Xia Z: Post-COVID conditions in people with multiple sclerosis: A cross-sectional multicenter study. American Academy of Neurology April 2024 Notes: Poster presentation; presented by co-author.
1bc Riley C, Venkatesh S, Dhand A, Doshi N, Kavak K, Levit E, Perrone C, Weinstock-Guttman B, Longbrake E, MSReCOV investigators, De Jager P, Xia Z: Impact of the COVID-19 pandemic on personal networks and neurological outcomes of people with multiple sclerosis: A case-control cross-sectional and longitudinal analysis. JMIR Public Health Surveill 10(e45429), February 2024.
211 Thebault S, Yamashita L, Breville G, Espinoza D, McGoldrick T, Woodson Z, Vitone M, Gandelman S, Windle A, Kadri J, Rezk A, Kim Y, Soldan S, Perrone CM, Jacobs D, Markowitz C, Jefferson A, Schindler M, Bar-Or A: Tandem CSF and blood flow-cytometric immune-cell profiling in the evaluation of neuroinflammatory conditions. Americas Committee for Treatment and Research in Multiple Sclerosis February 2024 Notes: Poster presentation; presented by co-author.
27e Kim E, Lane C, McCabe K, Gandelman S, Rivera-Torres N, Kakara M, Brandstadter R, Perrone C, Schindler M, Orthmann-Murphy J, Markowitz C, Berger J, Bar-Or A, Perrone E, Noon A, Johnson D, Carmolingo A, Fuller R, Lenzi K, Lee J, Mozes J, Leibowitz L, Pileggi C, Garabedian M, Zeccardi S, Sekella N, Samudralwar R, Stein L, Price R, Jacobs D: Penn multiple sclerosis and related disorders center’s approach towards addressing disparities in care in resident clinic. American Neurological Association September 2023 Notes: Poster presentation; presented by co-author.
2c
7
1d
1f
Selected Publications
1bf Oh J, Smolders J, Buijs F, Federer-Gsponer J, Meyer zu Hörste G, Mamdani M, Perrone C, Mowery DL, Kühnel T, van Tulder K, Testa C, Elze MC, Pedotti R, Kaczmarek L, Sharma V, Tackenberg B, Bar-Or A, Wiendl H: Integrating multicentre data to explore rwPIRMA: Results from the INTONATE-MS consortium. ECTRIMS September 2025 Notes: Poster presentation; presented by co-author.1a3 Cooper EC, Schindler MK, Bar-Or A, Brandstadter RB, Calkins ME, Gur R, Jacobs DA, Markowitz C, Moore T, Naydovich LR, Perrone CM, Ruparel K, Spangler BC, Troyan S, Shinohara RT, Satterthwaite TD, Baller EB: Investigating mood and cognition in people with multiple sclerosis: A prospective cross-sectional study protocol. BMJ Open 15(5), May 2025.
148 Baller EB, Luo AC, Schindler MK, Cooper EC, Pecsok MK, Cieslak MC, Martin ML, Bar-Or A, Elahi A, Perrone CM, Spangler BC, Satterthwaite TD, Shinohara RT: Uncinate Fasciculus Lesion Burden and Anxiety in Multiple Sclerosis. JAMA Netw Open 8(4), April 2025.
1b1 Martin ML, Robert-Fitzgerald T, Schindler MK, Perrone C, Schultz G, Lynch S, Mirkovic N, Thomas S, Elahi A, Reid D, Moore TM, Baller EB, Satterthwaite TD, Cieslak M, Covitz S, Adebimpe A, Manning A, Markowitz CE, Detre JA, Bar-Or A, Kakara M, Shinohara RT.: Impact of insurance status on MRI phenotypes in MS. Mult Scler Relat Disord 92(105919), December 2024.
1cd Oh J, Smolders J, Buijs F, Meyer zu Hörste G, Perrone C, van den Brand J, Federer-Gsponer J, Pedotti R, Kaczmarek L, Sharma V, Heinzmann D, Tackenberg B, Bar-Or A, Wiendl H: Defining PIRA and Lack of Disease Stability in the Real-World: Interim Results. European Committee for Treatment and Research in Multiple Sclerosis November 2024 Notes: Poster presentation; presented by co-author.
1de Baller EB, Sweeney EM, Cieslak MC, Robert-Fitzgerald T, Covitz SC, Martin ML, Schindler MK, Bar-Or A, Elahi A, Larsen BS, Manning AR, Markowitz CE, Perrone CM, Rautman V, Seitz MM, Detre JA, Fox MD, Shinohara RT, Satterthwaite TD: Mapping the relationship of white matter lesions to depression in multiple sclerosis. Biol Psychiatry 95(12): 1072-1080, June 2024 Notes: doi: 10.1016/j.biopsych.2023.11.010.
1a9 Son JY, Hu C, McAlpine L, Bar-Or A, Dahl M, Brito SF, Kavak K, Onomichi K, Perrone C, Riley C, Song E, Walker E, Weinstock-Guttmen B, De Jager P, Longbrake E, Xia Z: Post-COVID conditions in people with multiple sclerosis: A cross-sectional multicenter study. American Academy of Neurology April 2024 Notes: Poster presentation; presented by co-author.
1bc Riley C, Venkatesh S, Dhand A, Doshi N, Kavak K, Levit E, Perrone C, Weinstock-Guttman B, Longbrake E, MSReCOV investigators, De Jager P, Xia Z: Impact of the COVID-19 pandemic on personal networks and neurological outcomes of people with multiple sclerosis: A case-control cross-sectional and longitudinal analysis. JMIR Public Health Surveill 10(e45429), February 2024.
211 Thebault S, Yamashita L, Breville G, Espinoza D, McGoldrick T, Woodson Z, Vitone M, Gandelman S, Windle A, Kadri J, Rezk A, Kim Y, Soldan S, Perrone CM, Jacobs D, Markowitz C, Jefferson A, Schindler M, Bar-Or A: Tandem CSF and blood flow-cytometric immune-cell profiling in the evaluation of neuroinflammatory conditions. Americas Committee for Treatment and Research in Multiple Sclerosis February 2024 Notes: Poster presentation; presented by co-author.
27e Kim E, Lane C, McCabe K, Gandelman S, Rivera-Torres N, Kakara M, Brandstadter R, Perrone C, Schindler M, Orthmann-Murphy J, Markowitz C, Berger J, Bar-Or A, Perrone E, Noon A, Johnson D, Carmolingo A, Fuller R, Lenzi K, Lee J, Mozes J, Leibowitz L, Pileggi C, Garabedian M, Zeccardi S, Sekella N, Samudralwar R, Stein L, Price R, Jacobs D: Penn multiple sclerosis and related disorders center’s approach towards addressing disparities in care in resident clinic. American Neurological Association September 2023 Notes: Poster presentation; presented by co-author.
2c